Skip to content

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07166822
Enrollment
50
Registered
2025-09-10
Start date
2025-09-15
Completion date
2028-08-01
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular (CV) Risk, Exercise

Keywords

pregnant, cardiovascular, mobile app, exercise

Brief summary

The goal of this study is to determine the effectiveness of a mobile exercise app in improving cardiovascular health and motivation to exercise in pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and do not do exercise currently. The aims of this study are determine i) the effect of a mobile app (BumptUp) to increase motivation to exercise as assessed by questionnaire, and ii) the changes may occur in cardiovascular health outcomes such as increased percent Flow-Mediated Dilation (FMD), Heart Rate Variability (HRV), and decreased Pulse Wave Velocity (PWV) over an 8-week period of intervention. Researchers will compare this to pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and who will not be using the mobile app (BumptUp) for exercise. Participants who are in the experimental group will be given access to the mobile app (BumptUp) for 8 weeks. Both the control and experimental group will visit the lab for their baseline measurements (study visit 1), followed by two visits at 4 weeks (study visit 2) and 8 weeks (study visit 3) to have their heart rate variability, arterial stiffness (PWV), and vascular function (FMD) assessed. At each study visit, blood pressure, heart rate, height, and weight will also be measured. Additionally, at all three study visits, participants will fill out a questionnaire to determine motivation to exercise.

Interventions

BEHAVIORALExperimental group using BumptUp mobile exercise app

This BumptUp app has been developed specifically for pregnancy with safety and screening feature. This intervention will be unique since the researchers will evaluate the cardiovascular health outcomes following the 8 weeks of intervention.

Sponsors

Old Dominion University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-45 years. * Pregnant women who are 20-24 weeks pregnant at enrollment * Sedentary, as defined by completing less than 90 minutes of exercise each week. * Generally healthy, uncomplicated pregnancies. * Free of physical limitations that may interfere with alterations in daily physical activity levels. * Single gestation. * Have a smartphone * Under the routine medical care of an obstetrician or certified nurse midwife during their current pregnancy. * Women speaking English.

Exclusion criteria

* Physician diagnosed cardiovascular/ vascular complications (heart disease, high blood pressure, Raynaud's phenomenon etc.) * Physician diagnosed metabolic diseases (diabetes, hypothyroidism) * Musculoskeletal injuries (broken bones, back pain, ankle sprain, muscle pull, etc.) * Medications that may impact blood vessel function such as hypertension medication (Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker, beta blocker), lipid lowering agents (statins), Nitrates, steroids, etc. * Complications associated with pregnancy that would be exacerbated by exercise such as lung disease, persistent spotting/bleeding or Placental Previa, premature labor, ruptured membranes, evidence of intrauterine growth restriction, pregnancy induced hypertension or pre-eclampsia, uncontrolled epileptic fits/seizures. * Smoking within the previous 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Flow mediated dilation8 weeks of intervention periodThe cardiovascular health via flow mediated dilation (% change from baseline) will be assessed

Secondary

MeasureTime frameDescription
Arterial stiffness8 weeksCardiovascular health will be measured via arterial stiffness determining pulse wave velocity (m/sec)

Other

MeasureTime frameDescription
Heart rate variability8 weeksCardiovascular health will be measured via heart rate variability (msec).
motivation to exercise8 weeksMotivation to exercise will be measured via questionnaire

Countries

United States

Contacts

Primary ContactPrincipal Investigator, PhD
lreynold@odu.edu757-683-4974

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026